1. Home
  2. LCNB vs IPSC Comparison

LCNB vs IPSC Comparison

Compare LCNB & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LCNB Corporation

LCNB

LCNB Corporation

N/A

Current Price

$19.93

Market Cap

281.1M

Sector

Finance

ML Signal

N/A

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

N/A

Current Price

$1.78

Market Cap

248.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LCNB
IPSC
Founded
1877
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
281.1M
248.1M
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
LCNB
IPSC
Price
$19.93
$1.78
Analyst Decision
Hold
Buy
Analyst Count
3
5
Target Price
★ $20.83
$4.75
AVG Volume (30 Days)
20.2K
★ 972.2K
Earning Date
10-15-2026
11-20-2026
Dividend Yield
★ 4.49%
N/A
EPS Growth
68.04
★ 91.30
EPS
★ 1.35
N/A
Revenue
$6,445,000.00
★ $109,164,000.00
Revenue This Year
$11.08
N/A
Revenue Next Year
$0.51
N/A
P/E Ratio
$14.36
★ N/A
Revenue Growth
N/A
★ 1556.76
52 Week Low
$14.83
$0.44
52 Week High
$21.32
$2.97

Technical Indicators

Market Signals
Indicator
LCNB
IPSC
Relative Strength Index (RSI) 53.86 60.52
Support Level $18.44 $1.29
Resistance Level $20.48 $2.45
Average True Range (ATR) 0.55 0.16
MACD -0.00 0.04
Stochastic Oscillator 56.25 80.19

Price Performance

Historical Comparison
LCNB
IPSC

About LCNB LCNB Corporation

LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections, and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.

Share on Social Networks: